Dye-based chromoendoscopy versus i-scan virtual chromoendoscopy in long-standing ulcerative colitis: Multicenter prospective RCT

Alexander Jans; Pieter Sinonquel; Tom C J Seerden; Alexander De Bodelier; Rogier de Ridder; Marieke J Pierik; John Gásdal Karstensen; Stine Sloth; Gert De Hertogh; Ingrid Demedts; Hilde Willekens; Severine Vermeire; Raf Bisschops

doi:10.1055/a-2443-1080

Dye-based chromoendoscopy versus i-scan virtual chromoendoscopy in long-standing ulcerative colitis: Multicenter prospective RCT

Endosc Int Open. 2024 Nov 28;12(11):E1386-E1391. doi: 10.1055/a-2443-1080. eCollection 2024 Nov.

Authors

Affiliations

¹ Department of Gastroenterology and Hepotology, KU Leuven, Leuven, Belgium.
² Gastroenterology and Hepatology, Amphia Hospital Location Langendijk, Breda, Netherlands.
³ Department of Gastroenterology and Hepatology, Maastricht UMC+, Maastricht, Netherlands.
⁴ Gastro Unit, Division of Endoscopy, Hvidovre Hospital, Hvidovre, Denmark.
⁵ Department of Clinical Medicine, University of Copenhagen, Kobenhavn, Denmark.
⁶ Pathology, KU Leuven, Leuven, Belgium.
⁷ Gastroenterology, KU Leuven, Leuven, Belgium.
⁸ Gastroenterology, University Hospitals Leuven, Leuven, Belgium.
⁹ Department of Gastroenterology and Hepatology, University Hospital Leuven, Leuven, Belgium.

Abstract

Background and study aims Long-standing ulcerative colitis (UC) is associated with an increased risk of developing colorectal neoplasia. Both dye-based chromoendoscopy (DCE) and virtual chromoendoscopy (VCE) increase detection of neoplastic lesions. In this prospective randomized controlled trial (RCT), we compared the neoplasia detection rate between DCE and i-scan VCE in patients with long-standing UC. Patient and methods In four European hospitals, 131 patients with long-standing UC (disease duration > 8 years) were randomized to either DCE with methylene blue 0.1% (n = 66) or i-scan VCE (n = 65). All procedures were performed by trained endoscopists. Biopsies were taken from all visible lesions and the surrounding mucosa. Results The mean number of neoplastic lesions detected per colonoscopy was not significantly different between DCE (0.27) and i-scan VCE (0.37) ( P = 0.41). Similarly, there was no significant difference in neoplasia detection rate between DCE (19.7%) and VCE (27.7%) (odds ratio0.64, 95% confidence interval 0.28-1.50, P = 0.31). However, the per lesion neoplasia detection rate was significantly higher with i-scan VCE compared to DCE (27.6% vs 15.3%, P = 0.036). Both withdrawal and total procedure time were on average 10.0 and 9.9 minutes shorter using i-scan VCE (both P < 0.001). Conclusions This multicenter, prospective RCT showed no significant difference in neoplasia detection between DCE and i-scan VCE in long-standing UC. However, use of i-scan VCE was associated with a lower false-positive rate and a significantly shorter procedure time compared with DCE. I-scan VCE, therefore, could be a valid replacement for DCE in UC surveillance colonoscopies.

Keywords: CRC screening; Diagnosis and imaging (inc chromoendoscopy, NBI, iSCAN, FICE, CLE...); Endoscopy Lower GI Tract; Inflammatory bowel disease.

The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).